Literature DB >> 23431408

MiRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas.

Zhu-Mei Shi1, Xie-Feng Wang, Xu Qian, Tao Tao, Lin Wang, Qiu-Dan Chen, Xi-Rui Wang, Lei Cao, Ying-Yi Wang, Jun-Xia Zhang, Tao Jiang, Chun-Sheng Kang, Bing-Hua Jiang, Ning Liu, Yong-Ping You.   

Abstract

MicroRNAs (miRNAs) are single-stranded, 18- to 23-nt RNA molecules that function as regulators of gene expression. Previous studies have shown that microRNAs play important roles in human cancers, including gliomas. Here, we found that expression levels of miR-181b were decreased in gliomas, and we identified IGF-1R as a novel direct target of miR-181b. MiR-181b overexpression inhibited cell proliferation, migration, invasion, and tumorigenesis by targeting IGF-1R and its downstream signaling pathways, PI3K/AKT and MAPK/ERK1/2. Overexpression of IGF-1R rescued the inhibitory effects of miR-181b. In clinical specimens, IGF-1R was overexpressed, and its protein levels were inversely correlated with miR-181b expression. Taken together, our results indicate that miR-181b functions in gliomas to suppress growth by targeting the IGF-1R oncogene and that miR-181b may serve as a novel therapeutic target for gliomas.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23431408      PMCID: PMC3677265          DOI: 10.1261/rna.035972.112

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  26 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  The IGF-1 receptor in cancer biology.

Authors:  Renato Baserga; Francesca Peruzzi; Krysztof Reiss
Journal:  Int J Cancer       Date:  2003-12-20       Impact factor: 7.396

3.  MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor.

Authors:  Kar Lok Kong; Dora Lai Wan Kwong; Tim Hon-Man Chan; Simon Ying-Kit Law; Leilei Chen; Yan Li; Yan-Ru Qin; Xin-Yuan Guan
Journal:  Gut       Date:  2011-08-03       Impact factor: 23.059

Review 4.  The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches.

Authors:  Antonella De Luca; Monica R Maiello; Amelia D'Alessio; Maria Pergameno; Nicola Normanno
Journal:  Expert Opin Ther Targets       Date:  2012-03-23       Impact factor: 6.902

5.  MicroRNA-181b regulates NF-κB-mediated vascular inflammation.

Authors:  Xinghui Sun; Basak Icli; Akm Khyrul Wara; Nathan Belkin; Shaolin He; Lester Kobzik; Gary M Hunninghake; Miguel Pinilla Vera; Timothy S Blackwell; Rebecca M Baron; Mark W Feinberg
Journal:  J Clin Invest       Date:  2012-05-24       Impact factor: 14.808

6.  MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor.

Authors:  X Zhao; W Dou; L He; S Liang; J Tie; C Liu; T Li; Y Lu; P Mo; Y Shi; K Wu; Y Nie; D Fan
Journal:  Oncogene       Date:  2012-05-21       Impact factor: 9.867

7.  Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells.

Authors:  Hongping Xia; William K C Cheung; Samuel S Ng; Xiaochun Jiang; Songshan Jiang; Johnny Sze; Gilberto K K Leung; Gang Lu; Danny T M Chan; Xiu-Wu Bian; Hsiang-fu Kung; Wai Sang Poon; Marie C Lin
Journal:  J Biol Chem       Date:  2012-01-17       Impact factor: 5.157

8.  Prediction of mammalian microRNA targets.

Authors:  Benjamin P Lewis; I-hung Shih; Matthew W Jones-Rhoades; David P Bartel; Christopher B Burge
Journal:  Cell       Date:  2003-12-26       Impact factor: 41.582

9.  MiR-223 suppresses cell proliferation by targeting IGF-1R.

Authors:  Cheng You Jia; Hui Hui Li; Xu Chao Zhu; Yi Wei Dong; Da Fu; Qian Lei Zhao; Wei Wu; Xing Zhong Wu
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

Review 10.  MicroRNAs and glioblastoma: roles in core signalling pathways and potential clinical implications.

Authors:  Jiri Sana; Marian Hajduch; Jaroslav Michalek; Rostislav Vyzula; Ondrej Slaby
Journal:  J Cell Mol Med       Date:  2011-08       Impact factor: 5.310

View more
  46 in total

1.  MicroRNA-377 inhibited proliferation and invasion of human glioblastoma cells by directly targeting specificity protein 1.

Authors:  Rui Zhang; Hui Luo; Shuai Wang; Wanghao Chen; Zhengxin Chen; Hong-Wei Wang; Yuanyuan Chen; Jingmin Yang; Xiaotian Zhang; Wenting Wu; Shu-Yu Zhang; Shuying Shen; Qingsheng Dong; Yaxuan Zhang; Tao Jiang; Daru Lu; Shiguang Zhao; Yongping You; Ning Liu; Huibo Wang
Journal:  Neuro Oncol       Date:  2014-06-20       Impact factor: 12.300

Review 2.  Understanding the CREB1-miRNA feedback loop in human malignancies.

Authors:  Ya-Wen Wang; Xu Chen; Rong Ma; Peng Gao
Journal:  Tumour Biol       Date:  2016-04-09

3.  MicroRNA-181b regulates ALX/FPR2 receptor expression and proresolution signaling in human macrophages.

Authors:  Anna Maria Pierdomenico; Antonio Recchiuti; Felice Simiele; Marilina Codagnone; Veronica Cecilia Mari; Giovanni Davì; Mario Romano
Journal:  J Biol Chem       Date:  2014-12-11       Impact factor: 5.157

4.  MiR-181b modulates chemosensitivity of glioblastoma multiforme cells to temozolomide by targeting the epidermal growth factor receptor.

Authors:  Yunxiang Chen; Rui Li; Minhong Pan; Zhumei Shi; Wei Yan; Ning Liu; Yongping You; Junxia Zhang; Xiefeng Wang
Journal:  J Neurooncol       Date:  2017-05-13       Impact factor: 4.130

5.  Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma.

Authors:  Feng Zhi; Naiyuan Shao; Rong Wang; Danni Deng; Lian Xue; Qiang Wang; Yi Zhang; Yimin Shi; Xiwei Xia; Suinuan Wang; Qing Lan; Yilin Yang
Journal:  Neuro Oncol       Date:  2014-08-18       Impact factor: 12.300

6.  MicroRNA-181b is downregulated in non-small cell lung cancer and inhibits cell motility by directly targeting HMGB1.

Authors:  Yun Liu; Xu Hu; Daokui Xia; Songlin Zhang
Journal:  Oncol Lett       Date:  2016-09-28       Impact factor: 2.967

7.  Analysis of circulating microRNAs in adrenocortical tumors.

Authors:  Diana Rita Szabó; Michaela Luconi; Peter M Szabó; Miklós Tóth; Nikolette Szücs; János Horányi; Zoltán Nagy; Massimo Mannelli; Attila Patócs; Károly Rácz; Peter Igaz
Journal:  Lab Invest       Date:  2013-12-16       Impact factor: 5.662

Review 8.  Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.

Authors:  A R M Ruhul Amin; Phillip A Karpowicz; Thomas E Carey; Jack Arbiser; Rita Nahta; Zhuo G Chen; Jin-Tang Dong; Omer Kucuk; Gazala N Khan; Gloria S Huang; Shijun Mi; Ho-Young Lee; Joerg Reichrath; Kanya Honoki; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Bill Helferich; Chandra S Boosani; Maria Rosa Ciriolo; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; W Nicol Keith; Dipita Bhakta; Dorota Halicka; Elena Niccolai; Hiromasa Fujii; Katia Aquilano; S Salman Ashraf; Somaira Nowsheen; Xujuan Yang; Alan Bilsland; Dong M Shin
Journal:  Semin Cancer Biol       Date:  2015-03-06       Impact factor: 15.707

9.  MicroRNA-320a suppresses in GBM patients and modulates glioma cell functions by targeting IGF-1R.

Authors:  Tianzhu Guo; Ying Feng; Qingyang Liu; Xue Yang; Tao Jiang; Yan Chen; Quangeng Zhang
Journal:  Tumour Biol       Date:  2014-08-13

10.  MicroRNA-936 induces cell cycle arrest and inhibits glioma cell proliferation by targeting CKS1.

Authors:  Dong Wang; Tongle Zhi; Xiupeng Xu; Zhongyuan Bao; Liang Fan; Zheng Li; Jing Ji; Ning Liu
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.